A Single Arm 48-Week Follow-on Safety Study to a Core Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®
about
A Single Arm 48-Week Follow-on Safety Study to a Core Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Single Arm 48-Week Follow-on ...... ctitob®/Bramitob® Versus TOBI®
@en
type
label
A Single Arm 48-Week Follow-on ...... ctitob®/Bramitob® Versus TOBI®
@en
prefLabel
A Single Arm 48-Week Follow-on ...... ctitob®/Bramitob® Versus TOBI®
@en
P17
P1050
P1476
A Single Arm 48-Week Follow-on ...... n With Pseudomonas Aeruginosa)
@en
P1813
CT03Ext
@en
P3098
NCT01111383
P4844
P580
2009-09-01T00:00:00Z
P582
2011-05-01T00:00:00Z